Fish Oil Alters Tamoxifen-Modulated Expression of mRNAs That Encode Genes Related to Differentiation, Proliferation, Metastasis, and Immune Response in Rat Mammary Tumors

REFERENCES

• American Cancer Society . 2010 . Cancer Facts and Figures , Atlanta : American Cancer Society .
   Google Scholar
• Cleator , S J , Ahamed , E , Coombes , R C and Palmieri , C . 2009 . A 2009 update on the treatment of patients with hormone receptor-positive breast cancer . Clin Breast Cancer , 9 ( Suppl 1 ) : S6 – S17 .
   PubMed Web of Science ®Google Scholar
• Osborne , C K . 1998 . Tamoxifen in the treatment of breast cancer . N Engl J Med , 339 : 1609 – 1618 .
   PubMed Web of Science ®Google Scholar
• Vogel , V G . 2010 . Selective estrogen receptor modulators and aromatase inhibitors for breast cancer chemoprevention . Curr Drug Targets , 12 : 1874 – 1887 . Epub Dec 15
   Web of Science ®Google Scholar
• White , I N . 1999 . The tamoxifen dilemma . Carcinogenesis , 20 : 1153 – 1160 .
   PubMed Web of Science ®Google Scholar
• Manni , A , Xu , H , Washington , S , Aliaga , C Cooper , T . 2010 . The impact of fish oil on the chemopreventive efficacy of tamoxifen against development of N-methyl-N-nitrosourea induced rat mammary carcinogenesis . Cancer Prev Res (Phila) , 3 : 322 – 330 .
   PubMed Web of Science ®Google Scholar
• Shao , Y , Pardini , L and Pardini , R S . 1995 . Dietary menhaden oil enhances mitomycin C antitumor activity toward human mammary carcinoma MX-1 . Lipids , 30 : 1035 – 1045 .
   PubMed Web of Science ®Google Scholar
• Hardman , W E , Avula , C P , Fernandes , G and Cameron , I L . 2001 . Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 breast cancer xenografts . Clin Cancer Res , 7 : 2041 – 2049 .
   PubMed Web of Science ®Google Scholar
• Calviello , G . 2010 . Dietary omega-3 polyunsaturated fatty acids and cancer , Dordrecht , , Germany and New York : Springer .
   Google Scholar
• Smyth , G K . 2005 . “ Limma: linear models for microarray data ” . In Bioinformatics and Computational Biology Solutions using R and Bioconductor , Edited by: Gentleman , R , Carey , V , Dudoit , S , Irizarry , R and Huber , W . 397 – 420 . New York : Springer .
   Google Scholar
• Ashburner , M , Ball , C A , Blake , J A , Botstein , D Butler , H . 2000 . Gene ontology: tool for the unification of biology . The Gene Ontology Consortium. Nat Genet , 25 : 25 – 29 .
   PubMed Web of Science ®Google Scholar
• Gopinathan , L , Hannon , D B , Smith , R W III , Peters , J M and Vanden Heuvel , J P . 2008 . Regulation of peroxisome proliferator-activated receptors by e6-associated protein . PPAR Res , 2008 : 1 – 8 .
   Web of Science ®Google Scholar
• Banerjee , S , Dhar , G , Haque , I , Kambhampati , S Mehta , S . 2008 . CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells . Cancer Res , 68 : 7606 – 7612 .
   PubMed Web of Science ®Google Scholar
• Dhar , G , Banerjee , S , Dhar , K , Tawfik , O Mayo , M S . 2008 . Gain of oncogenic function of p53 mutants induces invasive phenotypes in human breast cancer cells by silencing CCN5/WISP-2 . Cancer Res , 68 : 4580 – 4587 .
   PubMed Web of Science ®Google Scholar
• Diez-Itza , I , Vizoso , F , Merino , A M , Sanchez , L M Tolivia , J . 1994 . Expression and prognostic significance of apolipoprotein D in breast cancer . Am J Pathol , 144 : 310 – 320 .
   PubMed Web of Science ®Google Scholar
• Stewart , L V , Song , K , Hsing , A Y and Danielpour , D . 2003 . Regulation of trespin expression by modulators of cell growth, differentiation, and apoptosis in prostatic epithelial cells . ExpCell Res , 284 : 303 – 315 .
   PubMed Web of Science ®Google Scholar
• Ulger , C , Toruner , G A , Alkan , M , Mohammed , M Damani , S . 2003 . Comprehensive genome wide comparison of DNA and RNA level scan using microarray technology for identification of candidate cancer-related genes in the HL-60 cell line . Cancer Genet Cytogenet , 147 : 28 – 35 .
   PubMed Web of Science ®Google Scholar
• Lottin , S , Adriaenssens , E , Dupressoir , T , Berteaux , N Montpellier , C . 2002 . Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells . Carcinogenesis , 23 : 1885 – 1895 .
   PubMed Web of Science ®Google Scholar
• Adriaenssens , E , Lottin , S , Dugimont , T , Fauquette , W Coll , J . 1999 . Steroid hormones modulate H19 gene expression in both mammary gland and uterus . Oncogene , 18 : 4460 – 4473 .
   PubMed Web of Science ®Google Scholar
• Rasmussen , A A and Cullen , K J . 1998 . Paracrine/autocrine regulation of breast cancer by the insulin like growth factors . Breast Cancer Res Treat , 47 : 219 – 233 .
   PubMed Web of Science ®Google Scholar
• Christofori , G , Naik , P and Hanahan , D . 1994 . A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis . Nature , 369 : 414 – 418 .
   PubMed Web of Science ®Google Scholar
• Manni , A , Badger , B , Wei , L , Zaenglein , A Grove , R . 1994 . Hormonal regulation of insulin like growth factor II and insulin-like growth factor binding protein expression by breast cancer cells in vivo: evidence for stromal epithelial interactions . Cancer Res , 54 : 2934 – 2942 .
   PubMed Web of Science ®Google Scholar
• Brunner , N , Yee , D , Kern , F G , Spang-Thomsen , M Lippman , M E . 1993 . Effect of endocrinetherapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II) . Eur J Cancer , 29A : 562 – 569 .
   PubMed Web of Science ®Google Scholar
• Guo , J , Shou , C , Meng , L , Jiang , B Dong , B . 2007 . Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer . Int J Cancer , 121 : 1296 – 1305 .
   PubMed Web of Science ®Google Scholar
• Jiang , Y , Liu , Y E , Lu , A , Gupta , A Goldberg , I D . 2003 . Stimulation of estrogen receptor signaling by gamma synuclein . Cancer Res , 63 : 3899 – 3903 .
   PubMed Web of Science ®Google Scholar
• Jia , T , Liu , Y E , Liu , J and Shi , Y E . 1999 . Stimulation of breast cancer invasion and metastasis by synuclein gamma . Cancer Res , 59 : 742 – 747 .
   PubMed Web of Science ®Google Scholar
• Ning , S , Pagano , J S and Barber , G N . 2011 . IRF7: Activation, regulation, modification and function . Genes Immun , 12 : 399 – 414 .
   PubMed Web of Science ®Google Scholar
• Romieu-Mourez , R , Solis , M , Nardin , A , Goubau , D Baron-Bodo , V . 2006 . Distinct roles for IFN regulatory factor (IRF)-3 and IRF-7 in the activation of antitumor properties of human macrophages . Cancer Res , 66 : 10576 – 10585 .
   PubMed Web of Science ®Google Scholar
• Andrews , H N , Mullan , P B , McWilliams , S , Sebelova , S Quinn , J E . 2002 . BRCA1 regulates the interferon gamma-mediated apoptotic response . J Biol Chem , 277 : 26225 – 26232 .
   PubMed Web of Science ®Google Scholar
• Berquin , I M , Edwards , I J and Chen , Y Q . 2008 . Multi-targeted therapy of cancer by omega-3 fatty acids . Cancer Lett , 269 : 363 – 377 .
   PubMed Web of Science ®Google Scholar
• Calder , P C , Yaqoob , P , Thies , F , Wallace , F A and Miles , E A . 2002 . Fatty acids and lymphocyte functions . Br J Nutr , 87 ( Suppl 1 ) : S31 – S48 .
   Web of Science ®Google Scholar
• Dobrzanski , M J , Reome , J B and Dutton , R W . 2000 . Type 1 and type 2 CD8+ effector T cell subpopulations promote long-term tumor immunity and protection to progressively growing tumor . J Immunol , 164 : 916 – 925 .
   PubMed Web of Science ®Google Scholar
• Sheu , B C , Lin , R H , Lien , H C , Ho , H N Hsu , S M . 2001 . Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer . J Immunol , 167 : 2972 – 2978 .
   PubMed Web of Science ®Google Scholar
• Dobrzanski , M J , Reome , J B , Hylind , J C and Rewers-Felkins , K A . 2006 . CD8-mediated type 1antitumor responses selectively modulate endogenous differentiated and nondifferentiated T cell localization, activation, and function in progressive breast cancer . J Immunol , 177 : 8191 – 8201 .
   PubMed Web of Science ®Google Scholar
• Hegyesi , H , Colombo , L , Pallinger , E , Toth , S Boer , K . 2007 . Impact of systemic histamine deficiency on the crosstalk between mammary adenocarcinoma and T cells . J Pharmacol Sci , 105 : 66 – 73 .
   PubMed Web of Science ®Google Scholar
• Joshi , N , Johnson , L L , Wei , W Q , Abnet , C C Dong , Z W . 2006 . Gene expression differences in normal esophageal mucosa associated with regression and progression of mild and moderate squamous dysplasia in a high-risk Chinese population . Cancer Res , 66 : 6851 – 6860 .
   PubMed Web of Science ®Google Scholar
• Kraft , S and Kinet , J P . 2007 . New developments in FcepsilonRI regulation, function and inhibition . Nat Rev Immunol , 7 : 365 – 378 .
   PubMed Web of Science ®Google Scholar
• Medina , V , Croci , M , Crescenti , E , Mohamad , N Sanchez-Jimenez , F . 2008 . The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment . Cancer Biol Ther , 7 : 28 – 35 .
   PubMed Web of Science ®Google Scholar
• Cheng , W L , Wang , C S , Huang , Y H , Liang , Y Lin , P Y . 2008 . Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer . Int J Cancer , 123 : 1787 – 1796 .
   PubMed Web of Science ®Google Scholar
• Devoogdt , N , Rasool , N , Hoskins , E , Simpkins , F Tchabo , N . 2009 . Overexpression of protease inhibitor-dead secretory leukocyte protease inhibitor causes more aggressive ovarian cancer in vitro and in vivo . Cancer Sci , 100 : 434 – 440 .
   PubMed Web of Science ®Google Scholar
• Devoogdt , N , Hassanzadeh Ghassabeh , G , Zhang , J , Brys , L De Baetselier , P . 2003 . Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells . Proc Natl Acad Sci U S A , 100 : 5778 – 5782 .
   PubMed Web of Science ®Google Scholar